Literature DB >> 21658894

Left subclavian artery coverage during thoracic endovascular aortic repair and risk of perioperative stroke or death.

Jayer Chung1, Karthikeshwar Kasirajan, Ravi K Veeraswamy, Thomas F Dodson, Atef A Salam, Elliot L Chaikof, Matthew A Corriere.   

Abstract

INTRODUCTION: Left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR) is often necessary due to anatomic factors and is performed in to up to 40% of procedures. Despite the frequency of LSA coverage during TEVAR, reported associations with risk of periprocedural stroke or death are inconsistent in reported literature. We examined the 2005-2008 American College of Surgeons National Surgical Quality Improvement Program Participant Use Data file to determine associations between LSA coverage during TEVAR and risk of perioperative stroke or death.
METHODS: Current procedural terminology (CPT) codes were used to identify patients undergoing TEVAR, LSA coverage, and subclavian revascularization. Patients undergoing coronary bypass, ascending aortic repair, abdominal aortic aneurysm repair, or nonvascular intra-abdominal procedures during the same operation were excluded. Perioperative stroke and mortality associations with LSA coverage were examined using logistic regression models for each outcome. Significance was assessed at α = 0.05, with univariable P < .05 required for multivariable model entry.
RESULTS: Eight hundred forty-five TEVAR procedures were identified, of which 52 patients were excluded due to additional major procedures performed with TEVAR. Seven hundred thirty-three of the remaining 793 procedures included CPT codes indicating primary placement of an initial thoracic endograft and form the basis of this analysis. LSA coverage occurred in 279 procedures (38%). Thirty-day stroke and mortality rates were 5.7% and 7.0%, respectively. LSA coverage was associated with increased 30-day risk of stroke in multivariable modeling (odds ratio [OR], 2.17 95% confidence interval [CI], 1.13-4.14; P = .019). Other significant multivariable risk factors for stroke included proximal aortic cuff placement during TEVAR (OR, 2.58; 95% CI, 1.30-5.16; P = .007) and emergency procedure status (OR, 3.60; 95% CI, 1.87-6.94; P < .001). No significant association between LSA coverage and perioperative mortality was identified (univariable OR, 1.70; 95% CI, 0.98-2.93; P = .0578).
CONCLUSION: LSA coverage during thoracic endovascular repair is associated with increased risk of perioperative stroke following TEVAR. Further evidence is needed to determine whether procedural modifications, including LSA revascularization, reduce the incidence of stroke associated with TEVAR. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21658894     DOI: 10.1016/j.jvs.2011.03.270

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  19 in total

1.  Endovascular therapy for thoracic aortic aneurysms: state of the art in 2012.

Authors:  Nicolas A Brozzi; Eric E Roselli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

2.  Contemporary evaluation of mortality and stroke risk after thoracic endovascular aortic repair.

Authors:  Frances Y Hu; Zachary B Fang; Bradley G Leshnower; Yazan Duwayri; William D Jordan; Theresa W Gillespie; Ravi K Veeraswamy
Journal:  J Vasc Surg       Date:  2017-05-11       Impact factor: 4.268

3.  Mid-term results of endovascular treatment with the Gore TAG device for degenerative descending thoracic aortic aneurysms.

Authors:  Junji Yunoki; Toru Kuratani; Yukitoshi Shirakawa; Kei Torikai; Kazuo Shimamura; Keiwa Kin; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-17

4.  One-stage hybrid procedure without sternotomy for treating thoracic aortic pathologies that involve distal aortic arch: a single-center preliminary study.

Authors:  Changwei Ren; Xi Guo; Lizhong Sun; Lianjun Huang; Yongqiang Lai; Shangdong Xu
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

5.  Thoracic Endovascular Aortic Repair With Left Subclavian Artery Coverage Is Associated With a High 30-Day Stroke Incidence With or Without Concomitant Revascularization.

Authors:  Rens R B Varkevisser; Nicholas J Swerdlow; Livia E V M de Guerre; Kirsten Dansey; Chun Li; Patric Liang; Christopher A Latz; Mathijs T Carvalho Mota; Hence J M Verhagen; Marc L Schermerhorn
Journal:  J Endovasc Ther       Date:  2020-05-21       Impact factor: 3.487

6.  A review of endovascular treatment of thoracic aorta disease.

Authors:  Gjs Tan; Plz Khoo; Kmj Chan
Journal:  Ann R Coll Surg Engl       Date:  2018-10-05       Impact factor: 1.891

7.  Clinical Outcomes of Left Subclavian Artery Coverage on Morbidity and Mortality During Thoracic Endovascular Aortic Repair for Distal Arch Aneurysms.

Authors:  Takeshi Baba; Takao Ohki; Yuji Kanaoka; Koji Maeda
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

8.  Thoracic endovascular aortic repair for patent ductus arteriosus in an elderly patient with congestive heart failure.

Authors:  Gentaro Kato; Mikizo Nakai; Noriyuki Tokunaga; Shuji Shimizu; Masahiro Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-24

9.  Compressed Amplatzer Vascular Plug II Embolization of the Left Subclavian Artery for Thoracic Endovascular Aortic Repair is Efficient and Safety Method Comparable to Conventional Coil Embolization.

Authors:  Kensuke Matsumoto; Yasufumi Ohuchi; Shinsaku Yata; Akira Adachi; Masayuki Endo; Shohei Takasugi; Shinya Fujii; Masayuki Hashimoto; Toshio Kaminou; Toshihide Ogawa; Yoshikazu Fujiwara; Munehiro Saiki; Motonobu Nishimura
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

10.  Application of triple-chimney technique using C-TAG and Viabahn or Excluder iliac extension in TEVAR treatment of aortic arch dilation diseases.

Authors:  Lixin Wang; Yulong Huang; Daqiao Guo; Xin Xu; Bin Chen; Junhao Jiang; Jue Yang; Zhenyu Shi; Ting Zhu; Zhihui Dong; Yun Shi; Xiao Tang; Jianing Yue; Xiang Hong; Gang Chen; Yihui Chen; Xiushi Zhou; Weiguo Fu; Yuqi Wang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.